- Email: [email protected]
Announcing a new open access journal
J AM ACAD DERMATOL VOLUME 71, NUMBER 5
genomic analysis. Although traditional disease-risk management is still advised, patients may be receptive to education on beneficial lifestyle changes, and should exert additional effort in this capacity. DTC genomic analysis is likely to improve with time, and it may someday become an important component of personalized health care. It is recommended that dermatologists stay abreast of this budding field. REFERENCES 1. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014;42:D1001-6.
Fogel et al 995
2. Bloss CS, Wineinger NE, Darst BF, Schork NJ, Topol EJ. Impact of direct-to-consumer genomic testing at long term follow-up. J Med Genet 2013;50:393-400. 3. Annas GJ, Elias S. 23andMe and the FDA. N Engl J Med 2014; 370:985-8. 4. Kaniwa N, Saito Y. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury. J Hum Genet 2013;58:317-26. 5. Aspinwall LG, Leaf SL, Kohlmann W, Dola ER, Leachman SA. Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling. J Am Acad Dermatol 2009;60: 745-57. 6. Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS. Characteristics of genomic test consumers who spontaneously share results with their health care provider. Health Commun 2014;29:105-8.
genomic analysis. Although traditional disease-risk management is still advised, patients may be receptive to education on beneficial lifestyle changes, and should exert additional effort in this capacity. DTC genomic analysis is likely to improve with time, and it may someday become an important component of personalized health care. It is recommended that dermatologists stay abreast of this budding field. REFERENCES 1. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014;42:D1001-6.
Fogel et al 995
2. Bloss CS, Wineinger NE, Darst BF, Schork NJ, Topol EJ. Impact of direct-to-consumer genomic testing at long term follow-up. J Med Genet 2013;50:393-400. 3. Annas GJ, Elias S. 23andMe and the FDA. N Engl J Med 2014; 370:985-8. 4. Kaniwa N, Saito Y. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury. J Hum Genet 2013;58:317-26. 5. Aspinwall LG, Leaf SL, Kohlmann W, Dola ER, Leachman SA. Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling. J Am Acad Dermatol 2009;60: 745-57. 6. Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS. Characteristics of genomic test consumers who spontaneously share results with their health care provider. Health Commun 2014;29:105-8.